IL1B and neoplasm: As Th9 cells play important roles in auto- and anti-tumor immunity, our studies suggest that therapeutic targeting IL-1β/IL-1R1 signaling may be beneficial in dampening Th9-mediated inflammation or may be bolstered to enhance tumor clearance.